Who Should Not Take Wegovy For Weight Loss Treatment?
Wegovy, an injectable prescription medication containing the active ingredient Semaglutide, has gained popularity as an effective treatment for weight loss. While it can be a valuable tool for individuals struggling with obesity, not everyone is a suitable candidate for Wegovy.
In this article, we’ll explore Wegovy contraindications, exclusions for its use and identify Individuals not suitable for Wegovy for weight loss treatment.
Who Should Avoid Wegovy?
Wegovy, belonging to the GLP-1 receptor agonists group, is generally well-tolerated by most individuals seeking weight loss. However, certain health conditions and circumstances may make Wegovy unsuitable for some individuals. Individuals not suitable for Wegovy comprise the following categories:
- History of Thyroid Tumours or Endocrine Conditions
- Allergic Reaction to Semaglutide
- Pregnancy and Planning for Pregnancy
History of Thyroid Tumours or Endocrine Conditions
Wegovy is contraindicated for individuals with a history of medullary thyroid carcinoma (MTC) or those diagnosed with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Before prescribing Wegovy, healthcare providers carefully consider these conditions to ensure patient safety.
Allergic Reaction to Semaglutide
Individuals who have experienced a serious allergic reaction to semaglutide, the active ingredient in Wegovy, are considered unsuitable candidates for Wegovy. Allergic reactions can manifest as swelling, difficulty breathing, severe rash or rapid heartbeat.
Pregnancy and Planning for Pregnancy
Unsuitable candidates for Wegovy also include pregnant individuals or those planning to conceive within the next two months. It is important to discuss any pregnancy-related concerns with your healthcare provider before starting Wegovy.
Wegovy Contraindications
The contraindications for Wegovy use are meant to ensure the safety of individuals considering Wegovy for weight loss treatment. Wegovy contraindications include a personal or family history of medullary thyroid carcinoma and Multiple Endocrine Neoplasia syndrome type 2. WEGOVY is also contraindicated in patients with known or proven hypersensitivity to semaglutide or any of the excipients in Wegovy. It is essential for healthcare providers to counsel patients regarding the potential risk of MTC and symptoms of thyroid tumours.
Potential Side Effects and Safety Concerns
While Wegovy can be an effective weight loss solution, it's important to be aware of potential side effects and restrictions on Wegovy prescription. Some of the notable side effects include:
- Pancreatitis: Wegovy may cause inflammation of the pancreas, leading to severe abdominal pain. Individuals experiencing persistent abdominal pain should discontinue Wegovy and seek medical attention promptly.
- Gallbladder Problems: Gallbladder problems, including the formation of gallstones, are possible side effects of Wegovy. Symptoms such as upper abdominal pain, fever, jaundice or clay-coloured stools should be reported to healthcare providers.
- Low Blood Sugar (Hypoglycemia): Individuals with type 2 diabetes, especially those taking other diabetes medications, should be cautious about the increased risk of low blood sugar associated with Wegovy. Recognising and treating hypoglycemia is important for patient safety.
- Kidney Problems: Wegovy may exacerbate kidney problems, particularly in individuals with pre-existing kidney issues. Adequate fluid intake is recommended to reduce the risk of dehydration.
- Serious Allergic Reactions: Immediate medical attention is necessary if individuals using Wegovy for weight loss treatment experience symptoms of a serious allergic reaction, such as swelling, difficulty breathing, severe rash or rapid heartbeat.
- Changes in Vision: Individuals with type 2 diabetes should monitor for changes in vision during Wegovy treatment and promptly inform their healthcare provider if any occur.
- Increased Heart Rate: An increase in heart rate may be observed while using Wegovy. Individuals should report any prolonged racing or pounding sensations in the chest to their healthcare provider.
- Depression or Thoughts of Suicide: Mental health changes, especially sudden shifts in mood or thoughts, should be closely monitored. Prompt reporting to healthcare providers is important in such cases.
It's essential for individuals considering Wegovy to weigh the potential benefits against these side effects and restrictions on Wegovy prescription. Regular communication with healthcare providers is key to managing any emerging issues during the course of treatment.
How to Buy Wegovy Online in the UK?
If you are considering buying Wegovy online in the UK as a weight loss solution, we offer a convenient option. The process involves completing a clinical consultation questionnaire, which is then reviewed by the in-house team of prescribers. Based on the provided information, the prescribers will advise on the suitability of Wegovy as a treatment option.
Final Thoughts
While Wegovy has emerged as a promising tool for weight loss, it is important to recognise that it is not suitable for everyone. Individuals with a history of certain health conditions, allergies or those in specific life circumstances should exercise caution or avoid Wegovy altogether. Regular communication with healthcare providers and adherence to contraindications and safety guidelines are essential for ensuring a safe and effective weight loss journey with Wegovy. As with any medication, the decision to use Wegovy should be a collaborative one between the individual and their healthcare provider, taking into account the individual's health history and unique circumstances.
Begin your online consultation for Wegovy at Pharmacy Planet with us. Explore contraindications and safety considerations before choosing this weight loss treatment. Take the first step towards a healthier you.
Authored By
HARMINDER ‘HARMY’ KAUR
BSc(hons) Pharmacy
GPhC Number: 2061107
Reviewed By
GURDEV SEHMI
BSc Pharm, MRPharmS, Independent Prescriber, Superintendent Pharmacist, Clinical Lead
GPhC Number: 2050925